Cargando…
Innovations in Evaluating Statin Benefit and Efficacy in Staphylococcus aureus Intracellular Infection Management
An emerging therapeutic approach in the treatment of infectious disease is to augment the host response through repurposing of well-tolerated, non-antibiotic, host-directed therapeutics. Earlier retrospective studies identify a positive association between statin use and a decreased risk of death du...
Autores principales: | Nesson, Erik T., McDowell, Susan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657138/ https://www.ncbi.nlm.nih.gov/pubmed/36361794 http://dx.doi.org/10.3390/ijms232113006 |
Ejemplares similares
-
Pleiotropic Effects of Statins: New Therapeutic Approaches to Chronic, Recurrent Infection by Staphylococcus aureus
por: Evans, Melissa D., et al.
Publicado: (2021) -
Differential effects of cotreatment of the antibiotic rifampin with host-directed therapeutics in reducing intracellular Staphylococcus aureus infection
por: Evans, Melissa D., et al.
Publicado: (2020) -
Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly
por: Krauss, Jennifer L., et al.
Publicado: (2019) -
Therapy of intracellular Staphylococcus aureus by tigecyclin
por: Kreis, Carolin A, et al.
Publicado: (2013) -
Intracellular staphylococcus aureus: Live-in and let die
por: Fraunholz, Martin, et al.
Publicado: (2012)